MSF report shows price of older HIV drugs decreasing, but salvage regimens are 18 times more expensive than first-line treatment
7-21 | Trade agreements and pressure on India’s ‘pharmacy of the developing world’ pose major threats to access Médecins Sans Frontières (MSF) today released the 18th edition of its HIV drug pricing report, Untangling the Web of Antiretroviral Price Reductions, at the International AIDS Conference in Durban, South Africa. The report finds that prices of older HIV drugs continue to decline, while newer drugs remain largely priced out of reach.
7-14 | Doctors Without Borders/Médecins Sans Frontières (MSF) denounced the exorbitant price governments and non-governmental organisations are required to pay to vaccinate vulnerable children. In the past few weeks, MSF has vaccinated more than 5,000 refugee children between ages six months and 15 years of age in several camps and settlements across Greece. MSF vaccinated refugee children against ten diseases, including pneumonia.
6-8 | So called “key populations” such as sex workers and men who have sex with men have both a higher risk of contracting HIV (*1) and a lower access to antiretroviral care due to stigma and discrimination as well as, in many instances, their illegal status and high mobility. New medications to prevent HIV negative people from contracting the virus (Pre-Exposure Prophylaxis, or PreP) are a promising tool to curtail the progression of the HIV pandemic, but access remains limited in the most affected areas of Southern Africa.
MSF calls on G7 leaders to urgently address the critical gaps in global response to public health emergencies and unite to lower the price of live-saving medicines
5-26 | Two years since the first signs of the West Africa Ebola outbreak, the world today is little more prepared to respond to such an emergency than it was then, warns international humanitarian aid organisation Médecins Sans Frontières (MSF), while the lack of R&D into needed medicines and exorbitant medicine prices requires urgent and united action from the world leaders gathered in Japan. Global Health Systems: ‘Don’t build a hospital without an emergency room’ As the leaders of the G7 countries* gather in Ise-Shim
Access Campaign: Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments that could save their lives
3-21 | Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF).